53 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 28554183 | A Pilot Trial of S-1 and Paclitaxel in Unresectable or Postoperative Recurrent Esophageal Squamous Cell Carcinoma Pretreated by Fluorouracil, Cisplatin, and Docetaxel Chemotherapy. | 2018 | 2 |
2 | 29488122 | A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial. | 2018 Sep | 1 |
3 | 27299887 | A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. | 2017 Mar | 1 |
4 | 27643822 | New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin. | 2017 | 1 |
5 | 28101359 | Effect of combined treatment with micelle-incorporated cisplatin (NC-6004) and S-1 on human gastric cancer xenografts. | 2016 Dec | 2 |
6 | 29874335 | S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil [Retraction]. | 2016 | 1 |
7 | 25550589 | Phase I study of S-1 plus fractional cisplatin as adjuvant chemotherapy for advanced gastric cancer in an outpatient setting (KOGC-03). | 2015 Jan | 1 |
8 | 25707610 | Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS). | 2015 Jun | 1 |
9 | 25933246 | S-1 combined with cisplatin versus cisplatin alone for the treatment of advanced gastric cancer: a pilot randomized-controlled trial. | 2015 Aug | 1 |
10 | 24090674 | Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404). | 2014 Feb | 1 |
11 | 25031751 | S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil. | 2014 | 3 |
12 | 25109221 | Efficacy of S-1 in non-small cell lung cancer. | 2014 Sep | 1 |
13 | 25120809 | S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil. | 2014 | 3 |
14 | 23507605 | [A case of a septic pulmonary embolism-related implanted central venous port]. | 2013 Mar | 1 |
15 | 23868010 | Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809. | 2013 Aug 6 | 1 |
16 | 23975509 | A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site. | 2013 Dec | 1 |
17 | 24394072 | [A case of gastric cancer accompanied by disseminated carcinomatosis of the bone marrow successfully controlled by S-1 and cisplatin combination therapy]. | 2013 Nov | 1 |
18 | 22584338 | [A case of disseminated carcinomatosis of bone marrow treated by S-1 and cisplatin after distal gastrectomy for early gastric cancer]. | 2012 May | 2 |
19 | 22860709 | S-1 for the treatment of gastrointestinal cancer. | 2012 Sep | 1 |
20 | 20809123 | Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer. | 2011 Jun | 3 |
21 | 21364592 | CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients. | 2011 Mar 29 | 1 |
22 | 21677485 | Efficacy and toxicity of S-1 plus cisplatin combination neoadjuvant chemotherapy in patients with oral cancer. | 2011 Jun | 1 |
23 | 22162925 | Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies. | 2011 | 1 |
24 | 20154479 | [Combination therapy of S-1 and 24-h infusion of cisplatin after palliative gastrectomy for stage IV gastric cancer]. | 2010 Feb | 1 |
25 | 20629834 | Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy. | 2010 Jul | 1 |
26 | 20647727 | [S-1-based chemotherapy for recurrent gastric cancer with peritoneal dissemination resulting in long-term survival--report of a case]. | 2010 Jul | 1 |
27 | 20820990 | A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). | 2010 Aug | 2 |
28 | 21224577 | [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion]. | 2010 Nov | 3 |
29 | 21430401 | Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2). | 2010 | 1 |
30 | 19056143 | A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer. | 2009 Jul | 1 |
31 | 18195541 | [A case of gastric cancer with multiple bone metastasis that responded to S-1 with low-dose cis-platinum]. | 2008 Jan | 2 |
32 | 18282805 | S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. | 2008 Mar | 1 |
33 | 18505092 | Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study. | 2008 Mar-Apr | 1 |
34 | 18751421 | Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer. | 2008 Jul-Aug | 1 |
35 | 19343150 | Advanced gastric cancer: an update and future directions. | 2008 Jul | 4 |
36 | 17673469 | Relationship between expression of vascular endothelial growth factor in tumor tissue from gastric cancers and chemotherapy effects: comparison between S-1 alone and the combination of S-1 plus CDDP. | 2007 Jul | 1 |
37 | 17687213 | [A case of curatively resected AFP producing gastric cancer with massive lymph node metastasis effectively treated by neoadjuvant-chemotherapy of S-1 and CDDP]. | 2007 Aug | 1 |
38 | 17699106 | (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. | 2007 Aug | 1 |
39 | 17701005 | Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study. | 2007 Aug | 2 |
40 | 17906439 | Medical treatment for advanced gastroesophageal adenocarcinoma. | 2007 Nov | 1 |
41 | 16619577 | Feasibility study of biweekly CPT-11 plus CDDP for S-1- and paclitaxel-refractory, metastatic gastric cancer. | 2006 Mar-Apr | 2 |
42 | 16767371 | Longterm survival of a Western patient with metastatic gastric cancer treated with S-1 plus cisplatin. | 2006 | 1 |
43 | 16897973 | [Clinical development of S-1 (TS-1) for advanced gastric cancer]. | 2006 Jun | 1 |
44 | 16898001 | [Combination chemotherapy with S-1 and cisplatin for non-small cell lung cancer]. | 2006 Jun | 1 |
45 | 16953072 | A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy. | 2006 Aug | 1 |
46 | 15757419 | Available options in chemotherapy for advanced gastric cancer: the current developments in Japan. | 2005 Feb | 1 |
47 | 15864718 | Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer. | 2005 | 1 |
48 | 15886300 | Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. | 2005 May | 2 |
49 | 15014017 | Combination phase I trial of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902). | 2004 Mar 1 | 1 |
50 | 15075664 | The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors. | 2004 Feb | 1 |